Your browser doesn't support javascript.
loading
Comparative analysis of the incidence and mortality of COVID-19 in Korean end-stage kidney disease patients: hemodialysis, peritoneal dialysis, and transplantation.
Cho, AJin; Jeong, Seon A; Park, Hayne Cho; Kim, Do Hyoung; Yoo, Kyung Don; Yoon, Hye Eun; Kim, Yang Gyun; Lee, Young-Ki.
Affiliation
  • Cho A; Department of Internal Medicine, Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
  • Jeong SA; Hallym Kidney Research Institute, Hallym University College of Medicine, Seoul, Republic of Korea.
  • Park HC; Korean Society of Nephrology, Seoul, Republic of Korea.
  • Kim DH; Department of Internal Medicine, Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
  • Yoo KD; Hallym Kidney Research Institute, Hallym University College of Medicine, Seoul, Republic of Korea.
  • Yoon HE; Department of Internal Medicine, Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
  • Kim YG; Hallym Kidney Research Institute, Hallym University College of Medicine, Seoul, Republic of Korea.
  • Lee YK; Basic-Clinical Convergence Research Institute, University of Ulsan, Ulsan, Republic of Korea.
Article in En | MEDLINE | ID: mdl-38934044
ABSTRACT

Background:

Patients with end-stage kidney disease (ESKD) are more susceptible to viral epidemics and are known to have higher incidence and death rates of coronavirus disease 2019 (COVID-19) compared to the general population. We determined COVID-19 incidence and mortality among chronic hemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KT) patients in Korea.

Methods:

We conducted a retrospective cohort study and data regarding Korean ESKD adults (aged ≥18 years) were obtained from the National Health Insurance Service of Korea from October 2020 to December 2021. We examined and compared the incidence of COVID-19-related infections and deaths among the patients receiving HD, PD, and KT.

Results:

Of all ESKD patients, 85,018 (68.1%) were on HD, 8,399 (6.7%) on PD, and 31,343 (25.1%) on KT. The COVID-19 incidence was 1.3% for HD, 1.2% for PD, and 1.5% for KT. COVID-19 mortality was 16.3% for HD, 12.2% for PD, and 4.7% for KT. PD patients had a lower incidence of infection compared to HD patients (odds ratio [OR], 0.76; 95% confidence interval [CI], 0.607-0.93), but KT patients had a significantly higher risk of infection (OR, 1.28; 95% CI, 1.13-1.44). Compared with HD, the risk of COVID-19-related death was not different for PD patients but was significantly lower for KT patients (hazard ratio, 0.55; 95% CI, 0.35-0.88).

Conclusion:

COVID-19 incidence was lower in PD patients than in HD patients, but mortality was not different between them. KT was associated with a higher risk of COVID-19 infection but lower mortality compared to HD.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Kidney Res Clin Pract Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Kidney Res Clin Pract Year: 2024 Document type: Article Country of publication: